|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/21/2024 |
$1.16 |
$1.19 |
$1.14 |
$1.16 |
26.30K | 03/22/2024 |
$1.16 |
$1.20 |
$1.14 |
$1.20 |
85.90K | 03/25/2024 |
$1.20 |
$1.21 |
$1.18 |
$1.20 |
104.80K | 03/26/2024 |
$1.21 |
$1.22 |
$1.17 |
$1.19 |
97.80K | 03/27/2024 |
$1.19 |
$1.22 |
$1.18 |
$1.22 |
46.90K |
|
Bolt Biotherapeutics is a clinical-stage biopharmaceutical company developing immunotherapies for the treatment of cancer.. Co.'s proprietary Boltbody ISAC (immune-stimulating antibody conjugate) platform technology combines tumor-targeting antibodies with immune-stimulating linker payloads to create productive anti-tumor immune responses. Co.'s lead product candidate, BDC-1001, is in clinical development for the treatment of patients with human epidermal growth factor receptor 2 (HER2)-expressing solid tumors, including gastroesophageal cancer. Co.'s second program, BDC-3042, is an agonist antibody targeting Dectin-2, an innate immune receptor found on the surface of macrophages. | |
|
Bolt Biotherapeutics (BOLT) has the following price history information. Looking back at BOLT historical stock prices for the last five trading days, on March 21, 2024, BOLT opened at $1.16, traded as high as $1.19 and as low as $1.14, and closed at $1.16. Trading volume was a total of 26.30K shares. On March 22, 2024, BOLT opened at $1.16, traded as high as $1.20 and as low as $1.14, and closed at $1.20. Trading volume was a total of 85.90K shares. On March 25, 2024, BOLT opened at $1.20, traded as high as $1.21 and as low as $1.18, and closed at $1.20. Trading volume was a total of 104.80K shares. On March 26, 2024, BOLT opened at $1.21, traded as high as $1.22 and as low as $1.17, and closed at $1.19. Trading volume was a total of 97.80K shares. On March 27, 2024, BOLT opened at $1.19, traded as high as $1.22 and as low as $1.18, and closed at $1.22. Trading volume was a total of 46.90K shares.
BOLT Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Bolt Biotherapeutics shares, starting with a $10,000 purchase of BOLT, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
02/05/2021 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$32.15 |
|
End price/share: |
$1.22 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-96.21% |
|
Average Annual Total Return: |
-64.76% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$379.37 |
|
Years: |
3.14 |
|
|
|
Date |
Close |
03/21/2024 | $1.16 | 03/22/2024 | $1.20 | 03/25/2024 | $1.20 | 03/26/2024 | $1.19 | 03/27/2024 | $1.22 |
|
|